Skip to main content
. Author manuscript; available in PMC: 2016 Apr 5.
Published in final edited form as: Stroke. 2009 Nov 19;41(1):34–40. doi: 10.1161/STROKEAHA.109.564955

Table 4. Univariate Analysis of Hematoma Expansion.

All Patients (n=34) P Value

With Expansion (n=5) No Expansion (n=29)
Age, y, mean±SD 79±9 73±11 0.420
Female 2 (40%) 14 (48%) 1.0
Past medical history, n
 Hypertension 5 (100%) 21 (72%) 0.309
 Atrial fibrillation 1 (20%) 5 (17%) 1.0
 Coronary artery disease 2 (40%) 4 (14%) 0.205
 Diabetes mellitus 1 (20%) 7 (24%) 1.0
 Hyperlipidemia 4 (80%) 5 (17%) 0.012
 Dementia 1 (20%) 3 (10%) 0.488
Clinical variables
 Glucose, mg/dL 161.2±32.6 142.3±49.3 0.295
 Systolic blood pressure, mm Hg 162.2±13.7 152.6±34.2 0.252
 Diastolic blood pressure, mm Hg 81.0±6.6 81.0±22.2 0.827
 Platelet count, 1000/μL 241.6±64.6 231.8±71.2 0.706
 Partial thromboplastin time 28.1 ±3.8 26.9±4.6 0.603
 International Normalized Ratio 1.8±0.8 1.4±0.6 0.089
Medications
 Use of antiplatelet agents on admission 1 (20%) 10 (34%) 1.0
 Use of warfarin on admission 1 (20%) 5 (17%) 1.0
 Use of statin on admission 1 (20%) 10 (34%) 1.0
Radiologic data
 Time from onset to first CT, h 6.8±5.3 6.0±3.4 0.888
 Time from onset to second CT, h 20.8±10.3 31.4±15.6 0.149
 WMH score 18.2±4.1 12.5±7.0 0.073
 Presence of intraventricular hemorrhage 0 7 (24%) 0.559
 Lobar ICH 5 (100%) 17 (59%) 0.137
 No. of microbleeds 4.8±7.2 7.6±14.1 0.880